Price Ceiling Rises For Over 500 Products

BMI's expectation that the proposed 7% reductions in the Czech Republic's pricing and reimbursement scheme in January 2010 would cause maximum consumer prices to actually rise[1] appears to have been validated. The changes, applied to products that had not undergone a State Institute for Drug Control (SUKL) annual review, see maximum pharmacy prices for 957 products changing, with 374 declining, 64 remaining equal and 519 drugs increasing in

To read the full article, please choose one of the following options: